5	CONTROLLED-TRIAL
24	POPULATION
31	BONE-MINERAL DENSITY
28	PERFORMANCE
4	25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE
33	BIPOLAR HEMIARTHROPLASTY
40	BAYESIAN PHYLOGENETIC INFERENCE
41	MULTIPLE SEQUENCE ALIGNMENT
36	BREAST-CANCER
42	TYROSINE KINASE INHIBITORS
49	APH(3')-IIIA
9	CREATINE SUPPLEMENTATION
39	INFORMED CHOICES
48	PHARMACOPHORE
30	FEMORAL-NECK FRACTURES
37	ADJUVANT CHEMOTHERAPY
2	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
46	MECHANISM
44	CRYSTAL-STRUCTURE
7	D SUPPLEMENTATION
15	ENERGY-LEVELS
35	RANDOMIZED-TRIAL
11	REACTION-RATE UNCERTAINTIES
20	CERVICAL-CANCER
13	GALACTIC AL-26
29	LESIONS
23	SCREENING-PROGRAM
27	WOMEN
45	BETA-LACTAMASES
19	EMISSION
22	CONVENTIONAL CYTOLOGY
25	SPECIMENS
47	COMBINATIONS
8	CORTICAL-NEURONS
34	INTERNAL-FIXATION
3	D-RECEPTOR
14	MASSIVE STARS
12	PROTON THRESHOLD STATES
10	THERMONUCLEAR REACTION-RATES
1	PROSTATE-CANCER RISK
38	DECISION INSTRUMENT
43	PROTEIN-KINASES
0	NERVE GROWTH-FACTOR
26	ACCURACY
6	SKELETAL-MUSCLE
18	EXPLOSIONS
21	RURAL CHINA
32	DISPLACED SUBCAPITAL FRACTURES
17	NUCLEOSYNTHESIS
16	AGB STARS
